Mark Tillotson has 18 years of experience in the Life Science industry in consulting and corporate Commercial, Strategy and Business Development/M&A roles. Most recently employed by Mölnlycke Health Care as Global Director, Strategy and Business Development, Wound Care, he is currently leveraging his deep expertise in strategy, marketing and sales topics (especially corporate strategy, pipeline ideation and prioritization, strategic marketing and Go-to-Market strategy) as a freelance consultant working with large and small healthcare organizations. With significant experience observing how drug development, indication and positioning decisions define the range of possible commercial outcomes, he has a particular interest in therapy area strategy and pipeline/portfolio strategy.